Compare Enzyme (MLN) vs eCash (XEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs eCash — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while eCash trades at Rp0.1179 (market cap Rp2,35T, Rp1,38T 24h volume). The key difference: eCash is far larger — about 17520.3× Enzyme's market cap, and eCash's supply is capped (20,1T / 21T XEC (96%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and eCash for 116 Days on average.
| MLN | XEC | |
|---|---|---|
Market Cap | Rp134,13M | Rp2,35T |
Volume (24h) | Rp104,56M | Rp1,38T |
Circulating Supply | 3,3M MLN | 20,1T / 21T XEC (96%) |
Typical Hold Time | 28 Days | 116 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
eCash (XEC) trades at Rp0.12135 with a market cap of Rp2.41 trillion, showing bullish technical signals from moving averages. The circulating supply is 20.1 trillion XEC out of a max 21 trillion, with 96% in circulation and an average hold time of 116 days. Recent neutral oscillators and RSI levels near 58 suggest balanced momentum, while ADX indicates a strong trend. No major protocol updates were noted in recent crypto news sources as of May 2026.
Overall outlook is cautiously optimistic due to bullish technical trends, but risks include high volatility and regulatory uncertainties. Key opportunities lie in network adoption growth, while major risks involve liquidity constraints and market sentiment shifts. Investors should monitor on-chain activity and exchange developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About eCash
ECash (XEC) is the rebranded version of Bitcoin Cash ABC (BCHA), itself a fork of Bitcoin (BTC) and Bitcoin Cash (BCH). It calls itself a "cryptocurrency that's designed to be used as electronic cash." ECash strictly aims to be a means of transaction used to pay for goods and services.
Read more on XEC →
